Literature DB >> 27911409

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis.

Francesca Gilli1, Darlene B Royce2, Andrew R Pachner2.   

Abstract

After intracerebral infection with the Theiler's Murine Encephalomyelitis Virus (TMEV), susceptible SJL mice develop a chronic-progressive demyelinating disease, with clinical features similar to the progressive forms of multiple sclerosis (MS). The mice show progressive disability with loss of motor and sensory functions, which can be assessed with multiple apparatuses and protocols. Among them, the Rotarod performance test is a very common behavioral test, its advantage being that it provides objective measurements, but it is often used assuming that it is straightforward and simple. In contrast to visual scoring systems used in some models of MS, which are highly subjective, the Rotarod test generates an objective, measurable, continuous variable (i.e., length of time), allowing almost perfect inter-rater concordances. However, inter-laboratory reliability is only achieved if the various testing parameters are replicated. In this manuscript, recommendations of specific testing parameters, such as size, speed, and acceleration of the rod; amount of training given to the animals; and data processing, are presented for the Rotarod test.

Entities:  

Mesh:

Year:  2016        PMID: 27911409      PMCID: PMC5226227          DOI: 10.3791/54616

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  Assessment of genetic susceptibility to ethanol intoxication in mice.

Authors:  Nathan R Rustay; Douglas Wahlsten; John C Crabbe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-12       Impact factor: 11.205

2.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

4.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Assessing post-stroke behavior in mouse models of focal ischemia.

Authors:  Mustafa Balkaya; Jan M Kröber; Andre Rex; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-12       Impact factor: 6.200

6.  The effect of FTY720 in the Theiler's virus model of multiple sclerosis.

Authors:  Libin Li; Makiko Matsumoto; Timothy J Seabrook; Celine Cojean; Volker Brinkman; Andrew R Pachner
Journal:  J Neurol Sci       Date:  2011-07-02       Impact factor: 3.181

Review 7.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  The effect of B-cell depletion in the Theiler's model of multiple sclerosis.

Authors:  Francesca Gilli; Libin Li; Sandra J Campbell; Daniel C Anthony; Andrew R Pachner
Journal:  J Neurol Sci       Date:  2015-10-08       Impact factor: 3.181

9.  Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.

Authors:  Istvan Pirko; Aaron J Johnson; Anne K Lohrey; Yi Chen; Jun Ying
Journal:  J Neurol Sci       Date:  2009-01-21       Impact factor: 3.181

10.  Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis.

Authors:  Reiner Ulrich; Arno Kalkuhl; Ulrich Deschl; Wolfgang Baumgärtner
Journal:  J Cell Mol Med       Date:  2009-01-14       Impact factor: 5.310

View more
  3 in total

1.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

2.  Determining the Bioenergetic Capacity for Fatty Acid Oxidation in the Mammalian Nervous System.

Authors:  Cory J White; Jieun Lee; Joseph Choi; Tiffany Chu; Susanna Scafidi; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2020-04-28       Impact factor: 4.272

3.  Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.

Authors:  Michael Linzey; Krista DiSano; Nora Welsh; Andrew Pachner; Francesca Gilli
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.